Velcade 3.5 mg lyophilized powder for injection Images
Generic Name: bortezomib
This medication has been identified as Velcade 3.5 mg lyophilized powder for injection. It is supplied by Takeda Pharmaceutical Company Limited.
Velcade is used in the treatment of Multiple Myeloma; Mantle Cell Lymphoma; Lymphoma and belongs to the drug class proteasome inhibitors. There is positive evidence of human fetal risk during pregnancy. Velcade 3.5 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Velcade
- Generic Name
- bortezomib
- Strength
- 3.5 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Proteasome inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 63020-0049
More about Velcade (bortezomib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: proteasome inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
